Regenxbio (RGNX) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 29, 2026, at the company’s headquarters in Rockville, Maryland.

• Shareholders are invited to vote on key proposals, including director elections, auditor ratification, executive compensation, and stock option exchanges.

Voting matters and shareholder proposals

• Election of three Class II directors: Jean Bennett, A.N. "Jerry" Karabelas, and Daniel Tassé, with board recommending votes in favor.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2026.

• Advisory vote on executive compensation (say-on-pay) recommended for approval.

• Approval sought for stock option exchange programs for both non-executive and executive employees.

• Board recommends voting in favor of all proposals.

Board of directors and corporate governance

• Board nominates three individuals for election as Class II directors at the annual meeting.